Article Processing Charges (APC)
The International Journal of Cancer Biology and Advanced Research (IJCBAR) is a premier international, open-access, peer-reviewed publication committed to pioneering advancements in cancer biology and oncology through cutting-edge research and multidisciplinary insights. Serving as an essential hub for scientists, oncologists, and global health experts, IJCBAR delves into the molecular mechanisms of cancer, tumor biology, innovative diagnostics, therapeutic strategies, immunotherapy, personalized medicine, and the broader socioeconomic impacts on cancer care. By tackling genetic predispositions, disease progression, emerging technologies, and public health initiatives, the journal champions evidence-based approaches that enhance survival rates and quality of life for cancer patients worldwide. Our open-access framework provides free, immediate access to all content, cultivating a worldwide network of specialists and driving breakthroughs in oncology without access restrictions. Every submission is subjected to stringent peer evaluation by distinguished editorial board experts, ensuring the highest standards of accuracy, innovation, and applicability in cancer research.
Our Article Processing Charge (APC) of $1,200 is structured to uphold IJCBAR's dedication to excellence and inclusivity in cancer biology. This fee supports critical operations, including meticulous peer review, professional copyediting and typesetting, and efficient online distribution via state-of-the-art digital systems. It also funds investments in robust hardware, software, and secure archival solutions, ensuring long-term availability of your research for clinical trials, oncology education, and future therapeutic developments. Contributors to IJCBAR gain amplified exposure in cancer databases, higher citation rates, and the chance to shape treatment guidelines, global health policies, and targeted cancer therapies. We invite a range of submissions, such as original investigations, comprehensive reviews, clinical case studies, and expert commentaries, all scrutinized to uphold scholarly rigor and propel progress in cancer biology and advanced research.
To foster diverse participation in cancer research, IJCBAR implements a robust Waiver Policy that acknowledges varying financial landscapes. We understand that research funding can be uneven, so we provide generous waivers for eligible authors from underfunded institutions or low-resource regions. These can be partial or complete and are assessed individually to promote equity and global collaboration. Waiver requests should be directed to the journal prior to submission for equitable review. This initiative reinforces our ethos of openness, enabling brilliant minds to share discoveries without economic barriers.
Furthermore, our Withdrawal Policy maintains clarity and equity throughout the publishing journey. Authors can retract their manuscript prior to the plagiarism screening at no charge. If withdrawal happens after plagiarism checks (within 24 hours) and initial formatting, a $199 fee applies. For papers that have completed peer review and are nearing publication, the cost rises to $479. Published articles incur a $569 withdrawal fee. These amounts account for the invested editorial and technical efforts, consistent with our open-access ethos, where payments are final once processed to offset review, editing, and distribution expenses.
Publishing in IJCBAR positions you at the forefront of cancer biology and advanced research, enabling your contributions to revolutionize tumor detection, refine treatment modalities, mitigate health inequities, and elevate patient outcomes on a global scale. With zero submission fees and convenient payment methods including credit cards or institutional billing, the experience is user-friendly. For questions or APC discussions, reach out to accounts@medscienspublishinggroup.com. Drive oncology forward-submit your manuscript today and transform cancer care globally!